Evidence map›Paper›PMID 31793237›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology2020

Polymer-mediated gene therapy: Recent advances and merging of delivery techniques.

Janelle W Salameh, Le Zhou, Sarah M Ward, Cristiam F Santa Chalarca, Todd Emrick, Marxa L Figueiredo

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Nonviral nanoparticle gene delivery into the CNS for neurological disorders and brain cancer applications.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Janelle W SalamehThe Weldon School of Biomedical Engineering and the Interdisciplinary Biomedical Sciences Program, Purdue University, West Lafayette, Indiana.ORCID 0000-0001-8458-9956
Le ZhouPolymer Science and Engineering Department, University of Massachusetts, Amherst, Massachusetts.
Sarah M WardPolymer Science and Engineering Department, University of Massachusetts, Amherst, Massachusetts.
Cristiam F Santa ChalarcaPolymer Science and Engineering Department, University of Massachusetts, Amherst, Massachusetts.
Todd EmrickPolymer Science and Engineering Department, University of Massachusetts, Amherst, Massachusetts.ORCID 0000-0003-0460-1797
Marxa L FigueiredoDepartment of Basic Medical Sciences and the Interdisciplinary Biomedical Sciences Program, Purdue University, West Lafayette, Indiana.

Funding

Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodeliveryR01CA196947 · NCI · PURDUE UNIVERSITY · PI FIGUEIREDO, MARXA L · 2016 to 2020
$1.9M
Facilitating Endogenous Bone Repair in Arthritis with Targeted IL-27 SonodeliveryR01AR069079 · NIAMS · PURDUE UNIVERSITY · PI FIGUEIREDO, MARXA L · 2018 to 2022
$1.7M
NCI NIH HHS R01 CA196947NIAMS NIH HHS R01 AR069079
6 · The paper itself

Abstract

The ability to safely and precisely deliver genetic materials to target sites in complex biological environments is vital to the success of gene therapy. Numerous viral and nonviral vectors have been developed and evaluated for their safety and efficacy. This study will feature progress in synthetic polymers as nonviral vectors, which benefit from their chemical versatility, biocompatibility, and ability to carry both therapeutic cargo and targeting moieties. The combination of synthetic gene carrying constructs with advanced delivery techniques promises new therapeutic options for treating and curing genetic disorders. This article is characterized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Therapeutic Approaches and Drug Discovery > Emerging Technologies.

Indexed as

Drug Delivery SystemsGenetic TherapyPolymersAnimalsCell Line, TumorHumansMiceNeoplasmsPolymers

Identifiers

PMID31793237
PMCPMC7676468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.